Enabling AI to Drive Innovation and Precision across Oncology R&D.
Journal:
Cancer discovery
Published Date:
Apr 18, 2026
Abstract
The use of integrated large-scale, multidomain datasets with artificial intelligence (AI) is now essential in drug discovery and development. Organizations that strategically invest in robust data infrastructure and fit-for-purpose AI solutions will accelerate the delivery of precision oncology therapeutics globally.
Authors
Keywords
No keywords available for this article.
